| |  08.11.2008
Recent Draths Patent Highlighted by American Chemical Society
Draths' recently issued patent on the conversion of lysine to caprolactam was featured by the American Chemical Society. To view the link, please click here.
07.17.2008CEO Jim Millis to speak at BIO Pacific Rim
Draths CEO Jim Millis will be speaking on a panel at the BIO Pacfic Rim Summit on Industrial Biotechnology and Bioenergy, Sept. 10-12 in Vancouver, British Columbia. To view the press release, please click here.
07.15.2008
Key Caprolactam Patent Issued
Drath Founder Dr. John Frost was awarded a patent for his work on the conversion of lysine to caprolactam.
04.09.2008
Draths Founders featured in New York Times
Draths Founders John Frost and Karen Draths are featured in a New Yortk Times story on the promise of renewable based chemicals. To view the article, please click here.
11.10.2007
Draths closes Series B Funding Round
Draths Corporation of Okemos MI closed a Series B round with a private placement from Khosla Ventures. The funding will be focused on strategic and technical development, with key elements including process scale-up and material science development.
|
